• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基酸转运体:在肿瘤靶向治疗药物递送中的新作用。

Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy.

作者信息

Zhang Ling, Sui Chengguang, Yang Wenhan, Luo Qiuhua

机构信息

Department of Biotherapy, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.

Department of Pharmacy, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.

出版信息

Asian J Pharm Sci. 2020 Mar;15(2):192-206. doi: 10.1016/j.ajps.2019.12.002. Epub 2020 Mar 5.

DOI:10.1016/j.ajps.2019.12.002
PMID:32373199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7193455/
Abstract

Amino acid transporters, which play a vital role in transporting amino acids for the biosynthesis of mammalian cells, are highly expressed in types of tumors. Increasing studies have shown the feasibility of amino acid transporters as a component of tumor-targeting therapy. In this review, we focus on tumor-related amino acid transporters and their potential use in tumor-targeting therapy. Firstly, the expression characteristics of amino acid transporters in cancer and their relationship with tumor growth are reviewed. Secondly, the recognition requirements are discussed, focusing on the "acid-base" properties, conformational isomerism and structural analogues. Finally, recent developments in amino acid transporter-targeting drug delivery strategies are highlighted, including prodrugs and nanocarriers, with special attention to the latest findings of molecular mechanisms and targeting efficiency of transporter-mediated endocytosis. We aim to offer related clues that might lead to valuable tumor-targeting strategies by the utilization of amino acid transporters.

摘要

氨基酸转运体在为哺乳动物细胞生物合成转运氨基酸过程中发挥着至关重要的作用,在多种肿瘤类型中高表达。越来越多的研究表明,氨基酸转运体作为肿瘤靶向治疗的一个组成部分具有可行性。在本综述中,我们聚焦于肿瘤相关氨基酸转运体及其在肿瘤靶向治疗中的潜在应用。首先,综述了氨基酸转运体在癌症中的表达特征及其与肿瘤生长的关系。其次,讨论了识别要求,重点关注“酸碱”性质、构象异构和结构类似物。最后,突出了氨基酸转运体靶向药物递送策略的最新进展,包括前药和纳米载体,特别关注转运体介导的内吞作用的分子机制和靶向效率的最新研究结果。我们旨在提供相关线索,以便通过利用氨基酸转运体来开发有价值的肿瘤靶向策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deaf/7193455/800e8ed5d2da/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deaf/7193455/a1aebd50ca12/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deaf/7193455/9d020a03c75d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deaf/7193455/81b90341c787/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deaf/7193455/800e8ed5d2da/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deaf/7193455/a1aebd50ca12/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deaf/7193455/9d020a03c75d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deaf/7193455/81b90341c787/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deaf/7193455/800e8ed5d2da/gr3.jpg

相似文献

1
Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy.氨基酸转运体:在肿瘤靶向治疗药物递送中的新作用。
Asian J Pharm Sci. 2020 Mar;15(2):192-206. doi: 10.1016/j.ajps.2019.12.002. Epub 2020 Mar 5.
2
Emerging transporter-targeted nanoparticulate drug delivery systems.新兴的靶向转运体的纳米颗粒药物递送系统。
Acta Pharm Sin B. 2019 Jan;9(1):49-58. doi: 10.1016/j.apsb.2018.10.005. Epub 2018 Oct 24.
3
Advancement in transporter-oriented nanoplatforms for cancer therapy.基于转运体的肿瘤治疗纳米平台的研究进展。
J Drug Target. 2023 Jun;31(5):456-470. doi: 10.1080/1061186X.2023.2197570. Epub 2023 Apr 5.
4
Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy.载体封闭状态构象诱导内吞作用:氨基酸转运体 ATB 介导的脂质体肿瘤靶向用于肝癌治疗的多西紫杉醇递送。
J Control Release. 2016 Dec 10;243:370-380. doi: 10.1016/j.jconrel.2016.10.031. Epub 2016 Nov 1.
5
The Na/Cl-Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis.钠离子/氯离子共转运体、广谱、氨基酸转运蛋白 SLC6A14(ATB):在多种疾病中的新作用及治疗和诊断的治疗潜力。
AAPS J. 2017 Dec 4;20(1):12. doi: 10.1208/s12248-017-0164-7.
6
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy.溶质载体转运体在高效抗癌药物递送与治疗中的作用
Pharmaceutics. 2023 Jan 21;15(2):364. doi: 10.3390/pharmaceutics15020364.
7
Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability.靶向肠道OCTN2和MCT1的药物递送以提高口服生物利用度。
Asian J Pharm Sci. 2020 Mar;15(2):158-173. doi: 10.1016/j.ajps.2020.02.002. Epub 2020 Mar 4.
8
Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1.通过靶向 MCT1、MCT4 和 LAT1 蛋白提高肿瘤治疗的新策略。
Eur J Med Chem. 2021 Dec 15;226:113806. doi: 10.1016/j.ejmech.2021.113806. Epub 2021 Aug 26.
9
Targeting L-type amino acid transporter 1 for anticancer therapy: clinical impact from diagnostics to therapeutics.靶向L型氨基酸转运体1进行抗癌治疗:从诊断到治疗的临床影响
Expert Opin Ther Targets. 2015;19(10):1319-37. doi: 10.1517/14728222.2015.1044975. Epub 2015 May 12.
10
L-Type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs).L 型氨基酸转运蛋白 1(LAT1)利用前药具有载体选择性,尽管对有机阴离子转运多肽(OATPs)的亲和力较低。
Int J Pharm. 2019 Nov 25;571:118714. doi: 10.1016/j.ijpharm.2019.118714. Epub 2019 Oct 11.

引用本文的文献

1
Reprogramming Atherosclerosis: Precision Drug Delivery, Nanomedicine, and Immune-Targeted Therapies for Cardiovascular Risk Reduction.重塑动脉粥样硬化:精准药物递送、纳米医学与免疫靶向疗法以降低心血管风险
Pharmaceutics. 2025 Aug 7;17(8):1028. doi: 10.3390/pharmaceutics17081028.
2
L‑type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review).L型氨基酸转运体1在增强硼中子俘获治疗中的作用:机制、挑战与未来方向(综述)
Int J Mol Med. 2025 Nov;56(5). doi: 10.3892/ijmm.2025.5611. Epub 2025 Aug 24.
3
Amino Acid Transporters in Glioblastoma: Implications for Diagnosis, Disease Monitoring, Therapeutic Targeting, and Drug Delivery.

本文引用的文献

1
Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB for efficient tumor therapy.酪氨酸修饰的载伊立替康脂质体能够同时靶向 LAT1 和 ATB,实现高效的肿瘤治疗。
J Control Release. 2019 Dec 28;316:22-33. doi: 10.1016/j.jconrel.2019.10.037. Epub 2019 Oct 30.
2
Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2.谷氨酰胺-β-环糊精通过转运体 ASCT2 靶向三阴性乳腺癌肿瘤递送阿霉素。
J Mater Chem B. 2019 Sep 11;7(35):5363-5375. doi: 10.1039/c9tb01225g.
3
The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.
胶质母细胞瘤中的氨基酸转运体:对诊断、疾病监测、治疗靶点及药物递送的意义
Mol Diagn Ther. 2025 Aug 22. doi: 10.1007/s40291-025-00810-9.
4
Dynamic crosstalk between amino acid metabolism and cancer drug efficacy: From mechanisms to therapeutic opportunities.氨基酸代谢与癌症药物疗效之间的动态相互作用:从机制到治疗机遇
iScience. 2025 Apr 11;28(5):112405. doi: 10.1016/j.isci.2025.112405. eCollection 2025 May 16.
5
Targeted drug delivery systems for atherosclerosis.用于动脉粥样硬化的靶向给药系统。
J Nanobiotechnology. 2025 Apr 23;23(1):306. doi: 10.1186/s12951-025-03384-0.
6
Applying metabolic control strategies to engineered T cell cancer therapies.将代谢控制策略应用于工程化T细胞癌症治疗。
Metab Eng. 2024 Nov;86:250-261. doi: 10.1016/j.ymben.2024.10.009. Epub 2024 Oct 25.
7
Dysfunction of the carnitine cycle in tumor progression.肉碱循环功能障碍在肿瘤进展中的作用
Heliyon. 2024 Aug 8;10(16):e35961. doi: 10.1016/j.heliyon.2024.e35961. eCollection 2024 Aug 30.
8
Clinical Significance of Carnitine in the Treatment of Cancer: From Traffic to the Regulation.卡尼汀在癌症治疗中的临床意义:从交通到调控。
Oxid Med Cell Longev. 2023 Aug 10;2023:9328344. doi: 10.1155/2023/9328344. eCollection 2023.
9
Investigation of molecular details of a bacterial cationic amino acid transporter (GkApcT) during arginine transportation using molecular dynamics simulation and umbrella sampling techniques.使用分子动力学模拟和伞式采样技术研究细菌阳离子氨基酸转运蛋白(GkApcT)在精氨酸转运过程中的分子细节。
J Mol Model. 2023 Jul 21;29(8):260. doi: 10.1007/s00894-023-05670-w.
10
Transporter-Mediated Drug Delivery.载体介导的药物递送。
Molecules. 2023 Jan 24;28(3):1151. doi: 10.3390/molecules28031151.
L 型氨基酸转运蛋白 1(LAT1)在癌症中的作用。
Curr Cancer Drug Targets. 2019;19(11):863-876. doi: 10.2174/1568009619666190802135714.
4
Emerging transporter-targeted nanoparticulate drug delivery systems.新兴的靶向转运体的纳米颗粒药物递送系统。
Acta Pharm Sin B. 2019 Jan;9(1):49-58. doi: 10.1016/j.apsb.2018.10.005. Epub 2018 Oct 24.
5
Cationic amino acid transporter PQLC2 is a potential therapeutic target in gastric cancer.阳离子氨基酸转运体 PQLC2 是胃癌的潜在治疗靶点。
Cancer Sci. 2019 Apr;110(4):1453-1463. doi: 10.1111/cas.13966. Epub 2019 Mar 19.
6
Glutamine Addiction and Therapeutic Strategies in Lung Cancer.谷氨酰胺成瘾与肺癌的治疗策略。
Int J Mol Sci. 2019 Jan 10;20(2):252. doi: 10.3390/ijms20020252.
7
L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.L 型氨基酸转运体 1 利用阿魏酸前药揭示了支持脑递药前药设计的结构特征。
Eur J Pharm Sci. 2019 Mar 1;129:99-109. doi: 10.1016/j.ejps.2019.01.002. Epub 2019 Jan 6.
8
mTOR: A Cellular Regulator Interface in Health and Disease.mTOR:健康与疾病中的细胞调节界面。
Cells. 2019 Jan 2;8(1):18. doi: 10.3390/cells8010018.
9
Metabolic pathways of L-arginine and therapeutic consequences in tumors.L-精氨酸的代谢途径及其在肿瘤中的治疗后果。
Adv Med Sci. 2019 Mar;64(1):104-110. doi: 10.1016/j.advms.2018.08.018. Epub 2018 Dec 31.
10
Grafted hyaluronic acid N-acetyl-l-methionine for targeting of LAT1 receptor: In-silico, synthesis and microscale thermophoresis studies.接枝透明质酸 N-乙酰-L-蛋氨酸用于 LAT1 受体靶向:计算机模拟、合成和微尺度热泳研究。
Int J Biol Macromol. 2019 Mar 15;125:767-777. doi: 10.1016/j.ijbiomac.2018.12.104. Epub 2018 Dec 13.